Teladoc Health (NYSE:TDOC) Earns Hold Rating from Needham & Company LLC

Teladoc Health (NYSE:TDOC)‘s stock had its “hold” rating restated by stock analysts at Needham & Company LLC in a research note issued to investors on Thursday,Benzinga reports.

A number of other research analysts also recently issued reports on TDOC. TD Cowen reduced their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. Oppenheimer cut their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Bank of America lifted their target price on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Piper Sandler reiterated an “overweight” rating and set a $13.00 price target (up from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. Finally, Barclays boosted their price objective on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $11.44.

Teladoc Health Trading Down 2.5 %

Shares of NYSE TDOC opened at $10.91 on Thursday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock’s 50 day moving average price is $10.61 and its two-hundred day moving average price is $9.53. Teladoc Health has a 52-week low of $6.76 and a 52-week high of $15.95. The stock has a market capitalization of $1.88 billion, a P/E ratio of -1.89 and a beta of 1.04.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. On average, analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insider Activity at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now owns 2,890 shares of the company’s stock, valued at $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.95% of the stock is currently owned by insiders.

Institutional Trading of Teladoc Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after buying an additional 1,029,829 shares in the last quarter. Point72 Asset Management L.P. lifted its holdings in Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock valued at $101,625,000 after acquiring an additional 2,813,568 shares during the last quarter. Renaissance Technologies LLC boosted its position in shares of Teladoc Health by 15.5% during the 4th quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider’s stock valued at $51,582,000 after purchasing an additional 763,265 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Teladoc Health by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock worth $35,894,000 after purchasing an additional 22,664 shares during the last quarter. Finally, Maple Rock Capital Partners Inc. raised its holdings in shares of Teladoc Health by 189.5% in the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after purchasing an additional 2,331,000 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.